BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23877867)

  • 1. Potential advantages of simvastatin as a novel anti-vitiligo arsenal.
    Feily A; Baktash D; Mohebbipour A; Feily A
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1982-3. PubMed ID: 23877867
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin in vitiligo: an update with recent review of the literature.
    Hasan R; Agarwal K; Podder I; Misitzis A; Schwartz RA; Wollina U; Lotti T; Grabbe S; Goldust M
    Int J Dermatol; 2021 Oct; 60(10):e390-e396. PubMed ID: 33554328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.
    Agarwal P; Rashighi M; Essien KI; Richmond JM; Randall L; Pazoki-Toroudi H; Hunter CA; Harris JE
    J Invest Dermatol; 2015 Apr; 135(4):1080-1088. PubMed ID: 25521459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
    Vanderweil SG; Amano S; Ko WC; Richmond JM; Kelley M; Senna MM; Pearson A; Chowdary S; Hartigan C; Barton B; Harris JE
    J Am Acad Dermatol; 2017 Jan; 76(1):150-151.e3. PubMed ID: 27986135
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.
    Kotyla PJ; Sliwinska-Kotyla B; Kucharz EJ
    J Rheumatol; 2006 Nov; 33(11):2361-3; author reply 2363. PubMed ID: 17086617
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of xanthoma disseminatum with simvastatin.
    Lee EH; Kang TW; Kim SC
    J Dermatol; 2011 Oct; 38(10):1015-7. PubMed ID: 21592199
    [No Abstract]   [Full Text] [Related]  

  • 7. Simvastatin administration.
    Patel A
    Am J Nurs; 2012 Aug; 112(8):20. PubMed ID: 22832450
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin may be a useful therapy in Dupuytren contracture.
    Namazi H; Emami MJ
    Med Hypotheses; 2006; 66(3):683-4. PubMed ID: 16343796
    [No Abstract]   [Full Text] [Related]  

  • 9. Simvastatin in psoriasis: ambiguous effects.
    Colsman A; Sticherling M
    Acta Derm Venereol; 2010 Jul; 90(4):411. PubMed ID: 20574609
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-term simvastatin treatment has no effect on plasma cytokine response in a human in vivo model of low-grade inflammation.
    Erikstrup C; Ullum H; Pedersen BK
    Clin Exp Immunol; 2006 Apr; 144(1):94-100. PubMed ID: 16542370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with hyper-IgD syndrome responding to simvastatin treatment.
    Attout H; Guez S; Ranaivo I; Jameerbaccus N; Series C
    Eur J Intern Med; 2008 Dec; 19(8):e82-3. PubMed ID: 19046710
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose simvastatin for aneurysmal subarachnoid hemorrhage.
    Chu Wong GK; Poon WS
    Neurosurgery; 2013 Sep; 73(3):E561-2. PubMed ID: 23756754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Simvastatin].
    Taéron C
    Rev Infirm; 2003 May; (91):39-40. PubMed ID: 12827760
    [No Abstract]   [Full Text] [Related]  

  • 14. Sitagliptin and simvastatin (juvisync).
    Med Lett Drugs Ther; 2011 Nov; 53(1377):89. PubMed ID: 22075668
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 16. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of simvastatin in plaque psoriasis: A pilot study.
    Shirinsky IV; Shirinsky VS
    J Am Acad Dermatol; 2007 Sep; 57(3):529-31. PubMed ID: 17707157
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
    Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951
    [No Abstract]   [Full Text] [Related]  

  • 19. Antineoplastic effects of simvastatin in experimental breast cancer.
    Kubatka P; Zihlavniková K; Kajo K; Péc M; Stollárová N; Bojková B; Kassayová M; Orendás P
    Klin Onkol; 2011; 24(1):41-5. PubMed ID: 21539141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.
    Kahri AJ; Valkonen MM; Vuoristo MK; Pentikäinen PJ
    Ann Pharmacother; 2004 Apr; 38(4):719. PubMed ID: 14966253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.